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Previewsand langerin molecules varied markedly
between short- and long-term LCs,
perhaps pointing to different modes of
antigen handling and presentation. Differ-
ential expression of the C-type lectins
DEC-205 (CD205), DC-SIGN (CD209),
and even langerin may be indicative for
different spectra of microorganisms that
are dealt with by the two types of LCs.
Do monocyte-derived LCs, which enter
the epidermis in response to a preceding,
inflammation-induced loss of LCs, stay
there for long-term and behave like
‘‘real’’ LCs? Sere´ et al. clearly show that
this is not the case. In the adult epidermis,
the persisting LC network is composed of
LCs derived from an Id2-dependent
precursor in the bone marrow, like in
newborn. Monocyte-derived LCs settle
in the epidermis only transiently. The pre-
sented work not only solves problems but
also identifies questions to be tackled. Do
long-term LCs also contribute to homeo-
stasis in the absence of an initial depletion768 Immunity 37, November 16, 2012 ª2012of LCs? In the Sere´ et al. study, UV irradi-
ation was the trigger for the subsequent
immigration of both short-term and long-
term LCs. Does low level immigration of
long-term LCs help to maintain the
steady-state density of the LC network,
in addition to self-renewal by local prolif-
eration? Clearly, the work of Sere´ et al.
forms a good base to build upon further
research into this important cell type of
the skin immune system.
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Immunoglobulin A (IgA) is the main intestinal antibody. In this issue of Immunity, Chen et al. (2012) show that
intestinal T cells enhance protective IgA responses by expressing a short isoform of the CEACAM1 protein.The intestine is home to trillions of
commensal microbes that confer many
metabolic capabilities to the host and fill
a niche that would otherwise be acces-
sible to pathogens (Sansonetti, 2004). In
spite of expressing a wealth of microbial
sensors, intestinal tissues peacefully
coexist with commensals without in-
ducing inflammation. This homeostatic
balance involves a continuous dialog
between microbes and intestinal immune
cells, which leads to the generation ofa dynamic state of hyporesponsiveness
against commensals and active readiness
against pathogens. A key mediator of
intestinal homeostasis is immunoglobulin
A (IgA), an antibody isotype produced by
B cells through class switching (Cerutti,
2008). IgA confers a noninflammatory
tone to the intestine by shaping the
composition of commensals (Wei et al.,
2011). IgA production and release onto
the mucosal surface require a close inter-
play of B cells with T follicular helper (Tfh)cells, T regulatory (Treg) cells, dendritic
cells, follicular dendritic cells, and epithe-
lial cells (Cerutti, 2008; Suzuki et al., 2010;
Tsuji et al., 2009). In spite of recent
advances, the mechanisms regulating
intestinal IgA responses remain unclear.
In this issue of Immunity, Chen et al.
(2012) show that intestinal T cells control
commensal bacteria and protect against
pathogens by inducing IgA through a
pathway involving preferential expression
of a short isoform of carcinoembryonic
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Previewsantigen cell adhesion molecule like 1
(CEACAM1), a transmembrane protein
mediating intercellular interactions and
intracellular signaling (Gray-Owen and
Blumberg, 2006). CEACAM1 is expressed
on the surface of various hematopoietic
and nonhematopoietic cells, except
natural killer and T cells. However,
T cells upregulate CEACAM1 expression
in response to cytokines or engagement
of T cell antigen receptor (TCR) by
antigen. CEACAM1 exists in multiple iso-
forms, each composed of an extracellular
domain with an amino-terminal Ig vari-
able-like motif mediating homophilic
cell-to-cell interaction and a carboxy-
terminal cytoplasmic domain mediating
signal transduction. Alternative splicing
generates CEACAM1 molecules that
contain either a long (L) or a short (S) cyto-
plasmic domain. The L domain includes
two immunoreceptor tyrosine-based
inhibitory motifs (ITIMs) that negatively
regulate signaling from various activating
receptors, including the TCR. The S
domain lacks ITIM motifs, but includes
a calmodulin-binding sequence that
transduces stimulating signals, at least
in vitro.
In addition to mediating homophilic
cell-to-cell interactions, the extracellular
domain of CEACAM1 recognizes bacteria
by binding conserved microbial sig-
natures (Gray-Owen and Blumberg,
2006). This property prompted Chen
et al. (2012) to explore the function
of CEACAM-1 in the intestine (Figure 1),
an environment heavily colonized by
bacteria. Compared to peripheral T cells,
intestinal T cells expressed more
CEACAM1 and displayed a CEACAM1-
S/CEACAM1-L ratio unexpectedly
skewed toward CEACAM1-S. Adoptive
transfer experiments indicated that
preferential CEACAM1-S expression was
not irreversibly imprinted in intestinal
T cells but rather required reversible
induction of the CEACAM1 messenger
RNA (mRNA) splicing machinery by
cues originating from the local micro-
environment. Induction of CEACAM1-S
followed a microbe-independent path-
way, because CEACAM1-S expression
remained elevated in intestinal T cells
from mice that either lacked the intestinal
microbiota or had defective signaling
via microbial sensors such as Toll-like
receptor (TLR) molecules and nucleotide
oligomerization domain (NOD) receptors.Chen et al. (2012) elegantly demonstra-
ted themucosal functions of CEACAM1-S
by overexpressing CEACAM1-S or
CEACAM1-L in T cells from either wild-
type (WT) or CEACAM1-deficient mice.
In spite of showing elevated T cell
apoptosis, WT mice expressing a
CEACAM1-S transgene (4STg) had fewer
naive T cells but more central memory
T cells and effector memory T cells. These
mice also showed an increased pro-
duction of cytokines typically associated
with T helper type-1 (Th1), Th2, Th17,
and Treg cells, including interleukin-2
(IL-2), IL-4, IL-10, IL-17, interferon-g
(IFN-g), and transforming growth factor-
b1 (TGF-b1). Furthermore, T cells from
4STg mice showed increased prolife-
ration, cytokine production, and activa-
tion-induced cell death in response to
TCR stimulation. A similar phenotype
was observed in Ceacam1/ mice
expressing a CEACAM1-S transgene
(Ceacam1/-4STg), whereas gene-tar-
geted mice expressing a CEACAM1-L
transgene (Ceacam1/-4LTg) showed
blunted signaling via the TCR. These find-
ings indicate that CEACAM1-S functions
as an autonomous signal transduc-
ing receptor that regulates the function
of T cells independently of its ability
to oppose the inhibitory function of
CEACAM1-L.
The findings by Chen et al. (2012) indi-
cate that CEACAM1-S promotes intes-
tinal homeostasis and immunity by
enhancing the activation of local effector
T cells. But how does CEACAM1-S signal
to T cells? Compared to intestinal T cells
from WT mice, intestinal T cells from
4STg mice showed a transcriptional
profile consistent with increased signaling
via nuclear factor of activated T cells
(NF-AT), a transcriptional activator that
undergoes nuclear import after being
dephosphorylated by a calmodulin-
dependent phosphatase known as calci-
neurin. NF-AT nuclear translocation was
increased in intestinal T cells from both
4STg and CEACAM1/-4STg mice,
suggesting that CEACAM1-S amplifies
signals from TCRor other NF-AT-inducing
receptors. Given that NF-AT proteins
form a family with multiple immune and
metabolic functions, it would be important
to elucidate whether CEACAM1-S in-
duces specific NF-AT activation patterns
in intestinal T cells and whether such
patterns are regulated by local signals,Immunity 37, Nincluding microbial signals. Additional
studies should establish whether the
induction of the splicing machinery gov-
erning CEACAM1-S expression requires
specific members of the NF-AT family.
Remarkably, Chen et al. (2012) found
that CEACAM1-S played an important
role in steady-state intestinal IgA
responses to commensals. Compared to
WT and CEACAM1-deficient mice, 4STg
and Ceacam1/-4STg mice showed
larger intestinal Peyer’s patches that
contained an increased proportion of
IgA-secreting B220IgA+ plasmablasts
but an equivalent proportion of IgA
class-switched B220+IgA+ B cells. Tg
mice also had more IgA-secreting plas-
mablasts in the lamina propria and
increased secretory IgA in the intestinal
lumen. The IgA-enhancing activity of
CEACAM1-S was associated with an
increased expression of programmed
cell death-1 (PD-1), an NF-AT-inducible
inhibitory receptor typically expressed
by Tfh cells (Crotty, 2011). These effector
T cells are specifically required for the
activation, expansion, survival, and selec-
tion of germinal center B cells expressing
class-switched antibodies with high
affinity for antigen, including IgA (Crotty,
2011). Tfh cells were increased in Peyer’s
patches from 4STg mice but decreased
in Peyer’s patches from Ceacam1/
mice, suggesting that CEACAM1-S
augments intestinal IgA responses by
facilitating the cognate interaction of
follicular B cells with TFH cells. Homophilic
engagement of CEACAM1-S on TFH cells
by CEACAM1-S on B cells may increase
the expression of CD40 ligand (CD40L),
an NF-AT-inducible T cell molecule that
cooperates with the cytokine TGF-b1 to
induce IgA class switching and pro-
duction in B cells (Cerutti, 2008). In this
regard, CEACAM1-S-expressing T cells
upregulated the expression of both
CD40L and latency-associated peptide
(LAP), a cell-bound precursor of the cyto-
kine TGF-b1 (Suzuki et al., 2010).
LAP was expressed by an unusual
subset of CD4+ Treg cells that lacked
the CD25 subunit of the interleukin-2
(IL-2) receptor and yet suppressed colitis
via TGF-b as conventional CD25-ex-
pressing Treg cells do. Remarkably,
CD4+CD25LAP+ Treg cells preferentially
expressed CEACAM1-S and required
CEACAM1-S for their induction by an
anti-CD3 antibody administered throughovember 16, 2012 ª2012 Elsevier Inc. 769
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Figure 1. Alternative Splicing of CEACAM1 mRNA Generates a CEACAM1-S Isoform That Is
Required for Gut Humoral Immunity
Microbe-independent signals generated by the intestinal microenvironment induce alternative splicing of
CEACAM1-encoding mRNA to generate a CEACAM1-S protein with a short (S) cytoplasmic domain in
T cells. Signals from CEACAM1-S stimulate the activation of T effector memoy (Tem) cells, T central
memory (Tcm) cells, Tfh cells, and Treg cells, which in turn promote induction of the noninflammatory
antibody isotype IgA. This induction involves the differentiation of B cells expressing IgM (purple surface
antibody) into plasma cells expressing IgA (intracellular red antibody). Subsequent translocation of
secreted IgA across epithelial cells generates secretory IgA antibodies that enter the intestinal lumen to
control the composition of the commensal microbiota and prevent tissue invasion by pathogens.
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Previewsthe oral route. In 4STg and CEACAM1/-
4STg mice, CD4+CD25LAP+ Treg cells
were not only expanded, but also exerted
an enhanced suppressive activity on the
inflammatory activity of IFN-g-producing
Th1 cells. In addition to suppressing
inflammation, Treg cells induce nonin-
flammatory IgA production by trigger-
ing IgA class switching in B cells via
CD40L, TGF-b1, and IL-21 (Tsuji et al.,
2009). However, it remains unclear
whether also CEACAM1-S-expressing
CD4+CD25LAP+ Treg cells have this
effect, because WT and S4Tg mice
have comparable numbers of B220+IgA+
B cells in Peyer’s patches. Furthermore,
the presence of CD4+CD25LAP+ Treg
cells in Peyer’s patches remains untested.
CEACAM1-S may optimize the quality
of intestinal IgA responses through its
ability to enhance the expression of the
inhibitory receptor PD-1 on Tfh cells. As
shown by recent studies (Kawamoto770 Immunity 37, November 16, 2012 ª2012et al., 2012), increased PD-1 signaling
may restrain the clonal expansion and
activation of TFH cells, thereby causing
a more stringent selection of high-
affinity IgA-expressing B cells in Peyer’s
patches. It remains to be tested whether
CEACAM1-S also modulates the ex-
pression of interleukin-21 (IL-21), a TFH
cell-associated cytokine that cooperates
with CD40L and TGF-b1 to induce IgA
class switching and production (Cerutti,
2008). CEACAM1-S-mediated regulation
of key TFH cell-associated IgA-inducing
molecules could explain the altera-
tions of the gut microbiota that Chen
et al. (2012) observed in 4STg and
CEACAM1-deficient mice. In addition to
facilitating homeostatic IgA responses to
noninvasive commensals, CEACAM1-S
enhanced IgA responses to invasive
pathogens such as Listeria monocyto-
genes. Indeed, compared to WT and
Ceacam1/ mice, 4STg mice producedElsevier Inc.more abundant secretory IgA to Listeria
monocytogenes, which correlated with
a decreased invasion of intestinal and
systemic tissues by this pathogen.
More than 75% of human genes
undergo alternative splicing, with a bias
toward genes of the immune system,
including T cells (Lynch, 2004). This
process generates multiple mRNAs that
lead to the expression of multiple iso-
forms of the same protein. The findings
by Chen et al. (2012) show that intestinal
T cells with effector and regulatory func-
tions take advantage of alternative
splicing as a means to generate homeo-
stasis and immunity via CEACAM1-S.
Future studies should identify the intes-
tinal signals required for CEACAM-S
expression by T cells, precisely define
the intestinal ligands of CEACAM1-S,
and elucidate the mechanisms whereby
CEACAM1-S regulates intestinal T cell
activation and IgA production.REFERENCES
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